OXALIPLATIN AN oxaliplatin 50 mg powder for injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin an oxaliplatin 50 mg powder for injection vial

juno pharmaceuticals pty ltd - oxaliplatin, quantity: 50 mg - injection, powder for - excipient ingredients: lactose monohydrate - oxaliplatin is indicated for adjuvant treatment of stage iii (duke's c) colon cancer, in combination with a fluoropyrimidine agent,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN AG oxaliplatin 200 mg/40 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin ag oxaliplatin 200 mg/40 ml concentrated injection vial

alphapharm pty ltd - oxaliplatin, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke's c) colon cancer, in combination with a fluoropyrimidine agent,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN AG oxaliplatin 100 mg/20 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin ag oxaliplatin 100 mg/20 ml concentrated injection vial

alphapharm pty ltd - oxaliplatin, quantity: 100 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke's c) colon cancer, in combination with a fluoropyrimidine agent,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN AG oxaliplatin 50 mg/10 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin ag oxaliplatin 50 mg/10 ml concentrated injection vial

alphapharm pty ltd - oxaliplatin, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke's c) colon cancer, in combination with a fluoropyrimidine agent,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN AN oxaliplatin 200 mg/40 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin an oxaliplatin 200 mg/40 ml concentrated injection vial

juno pharmaceuticals pty ltd - oxaliplatin, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke's c) colon cancer, in combination with a fluoropyrimidine agent,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN AN oxaliplatin 100 mg/20 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin an oxaliplatin 100 mg/20 ml concentrated injection vial

juno pharmaceuticals pty ltd - oxaliplatin, quantity: 100 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke's c) colon cancer, in combination with a fluoropyrimidine agent,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN AN oxaliplatin 50 mg/10 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin an oxaliplatin 50 mg/10 ml concentrated injection vial

juno pharmaceuticals pty ltd - oxaliplatin, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - oxaliplatin is indicated for adjuvant treatment of stage iii (duke's c) colon cancer, in combination with a fluoropyrimidine agent,oxaliplatin in combination with fluorouracil and folinic acid is indicated for the treatment of advanced colorectal cancer,oxaliplatin in combination with capecitabine, with or without bevacizumab, is indicated for the treatment of patients with metastatic colorectal cancer,oxaliplatin in combination with epirubicin and either capecitabine or fluorouracil, is indicated for the treatment of patients with advanced oesophagogastric cancer

OXALIPLATIN INTAS oxaliplatin 100 mg/20 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin intas oxaliplatin 100 mg/20 ml concentrated injection vial

accord healthcare pty ltd - oxaliplatin, quantity: 100 mg - injection, concentrated - excipient ingredients: water for injections; lactose monohydrate - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; treatment of advanced colorectal cancer.

OXALIPLATIN INTAS oxaliplatin 50 mg/10 mL concentrated injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

oxaliplatin intas oxaliplatin 50 mg/10 ml concentrated injection vial

accord healthcare pty ltd - oxaliplatin, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections; lactose monohydrate - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; treatment of advanced colorectal cancer.

OXALIPLATIN powder for solution США - англійська - NLM (National Library of Medicine)

oxaliplatin powder for solution

mylan institutional llc - oxaliplatin (unii: 04zr38536j) (oxaliplatin - unii:04zr38536j) - oxaliplatin 50 mg in 10 ml